MoneyWorks4Me

Lupin submits analyst meet intimation

07 Feb 2025 Evaluate
Pursuant to Regulation 30(2) read with Schedule III Part A Para A (15) of the Listing Regulations, Lupin has informed that the Company will be participating in the Analyst/ Institutional Investors Meet on February 13 and 14, 2025.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..